Antibiotic treatment administered to each patient for 14 days beginning at day 0 and microorganisms cultured in sputum samples at day 0 and day 14
Patient no | Treatment | Microorganisms | |
---|---|---|---|
Day 0 | Day 14 | ||
1 | Cefotaxime/gentamicin | H influenzae | Insignificant commensals |
2 | Augmentin | P aeruginosa | P aeruginosa |
3 | Tazocin/tobramycin | H parainfluenzae | Insignificant commensals |
4 | Tazocin/gentamicin | P aeruginosa | P aeruginosa |
5 | Tazocin/tobramycin | P aeruginosa | No growth |
6 | Ceftazidime | H influenzae | Insignificant commensals |
7 | Ceftazidime/flucloxacillin | No growth | No growth |
8 | Ceftazidime/aztereonam | No growth | P aeruginosa |
9 | Ceftazidime | No growth | No growth |
10 | Cefotaxime | Insignificant commensals | H influenzae |
11 | Meropenem/gentamicin/nebulised colistin | P aeruginosa | No growth |
12 | Ceftazidime | P aeruginosa | No growth |
13 | Ceftazidime | No growth | No growth |
14 | Cefotaxime | H influenzae | Insignificant commensals |
15 | Ceftazidime/gentamicin | P aeruginosa | Insufficient sample |